LobbyingPOINT32HEALTH lobbying by quarter
POINT32HEALTH's latest lobbying report covers Q2 2026, at $126K. The four quarters Q4 2025–Q3 2026 total $368.3K. Its first report covers Q2 2021; the issues it reports most are Health Issues.
POINT32HEALTH
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $368.3K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q2 2021
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2021 | $160K | 1 |
| Q3 2021 | $160K | 1 |
| Q4 2021 | $163K | 1 |
| Q1 2022 | $170K | 1 |
| Q2 2022 | $153K | 1 |
| Q3 2022 | $156K | 1 |
| Q4 2022 | $159K | 1 |
| Q1 2023 | $170K | 1 |
| Q2 2023 | $167K | 1 |
| Q3 2023 | $168.9K | 1 |
| Q4 2023 | $166.1K | 1 |
| Q1 2024 | $154.8K | 1 |
| Q2 2024 | $155.4K | 1 |
| Q3 2024 | $154.8K | 1 |
| Q4 2024 | $155.4K | 1 |
| Q1 2025 | $108.6K | 1 |
| Q2 2025 | $108.6K | 1 |
| Q3 2025 | $108.6K | 1 |
| Q4 2025 | $116.3K | 1 |
| Q1 2026 | $126K | 1 |
| Q2 2026 | $126K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$3.1M · 21 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)21 reports
- HOUSE OF REPRESENTATIVES21 reports
- SENATE21 reports
- Agriculture, Dept of (USDA)12 reports
- Internal Revenue Service (IRS)8 reports
- Labor, Dept of (DOL)8 reports
- Treasury, Dept of8 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-housePOINT32HEALTH | $3.1M | 21 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $126K |
| 04/21for Q1 | In-house | $126K |
| 02/24for Q4 2025 | In-house | $116.3K |
| 25/10/16for Q3 2025 | In-house | $108.6K |
| 25/07/18for Q2 2025 | In-house | $108.6K |
| 25/04/18for Q1 2025 | In-house | $108.6K |
| 25/01/21for Q4 2024 | In-house | $155.4K |
| 24/10/18for Q3 2024 | In-house | $154.8K |
| 24/07/18for Q2 2024 | In-house | $155.4K |
| 24/04/18for Q1 2024 | In-house | $154.8K |
| 24/01/19for Q4 2023 | In-house | $166.1K |
| 23/10/19for Q3 2023 | In-house | $168.9K |
| 23/07/20for Q2 2023 | In-house | $167K |
| 23/04/22for Q4 2022 | In-house | $159K |
| 23/04/22for Q3 2022 | In-house | $156K |
| 23/04/22for Q2 2022 | In-house | $153K |
| 23/04/22for Q1 2022 | In-house | $170K |
| 23/04/22for Q4 2021 | In-house | $163K |
| 23/04/22for Q3 2021 | In-house | $160K |
| 23/04/22for Q2 2021 | In-house | $160K |